Brandinium

Trademark search for:

GENTITAN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2023-03-15 — Application filed
  • 2023-05-11 — Sn assigned for sect 66a appl from ib
  • 2023-05-16 — Application filed
  • 2023-05-17 — Application filed
  • 2023-05-23 — Application filed
  • 2023-08-15 — Assigned to examiner
  • 2023-08-16 — Approved for pub - principal register
  • 2023-08-25 — New representative at ib received
  • 2023-08-30 — Notice of publication
  • 2023-08-30 — Notice of start of opposition period created, to be sent to ib
  • 2023-08-30 — Notification of possible opposition sent to ib
  • 2023-09-18 — Notification processed by ib
  • 2023-09-19 — Published for opposition
  • 2023-09-21 — Letter of protest evidence forwarded
  • 2023-09-25 — Jurisdiction restored to examining attorney
  • 2023-09-26 — Previous allowance count withdrawn
  • 2023-10-05 — Extension of time to oppose received
  • 2023-10-12 — Jurisdiction restored to examining attorney
  • 2024-01-17 — Opposition papers received at ttab
  • 2024-01-18 — Office action issued
  • 2024-01-18 — Office action issued
  • 2024-01-25 — Opposition instituted no. 999999
  • 2024-02-02 — Teas change of owner address received
  • 2024-02-02 — Applicant/correspondence changes (non-responsive) entered
  • 2024-02-02 — Teas revoke/app/change addr of atty/dom rep received
  • 2024-02-02 — Attorney/dom.rep.revoked and/or appointed
  • 2024-02-02 — Teas change of correspondence received
  • 2024-02-06 — Office action issued
  • 2024-10-09 — Notification of possible opposition created, to be sent to ib
  • 2024-10-09 — Notification of possible opposition sent to ib
  • 2024-10-26 — Notification of possible opposition - processed by ib
  • 2025-03-17 — Letter of protest evidence reviewed - action taken
  • 2025-03-17 — Jurisdiction restored to examining attorney
  • 2025-04-17 — Final disposition recorded
  • 2025-04-18 — Office action issued
  • 2025-04-18 — Office action issued
  • 2025-04-18 — Office action issued
  • 2025-04-30 — Office action issued
  • 2025-05-24 — Office action issued
  • 2025-11-03 — Application abandoned
  • 2025-11-03 — Application abandoned
  • 2025-11-03 — Final status recorded

Owner Information

Nanjing Genscript Biotech Co., Ltd.
CN
Nanjing Genscript Biotech Co., Ltd.
CN

Correspondent

YUE ROBERT XU APEX ATTORNEYS AT LAW LLP
160 ALAMO PLAZA
#942
ALAMO, 94507

Filing Details

Filing Date:
2023-03-15
Status Date:
2025-11-03
Filing Year:
2023

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.